Authorities In DRC Approve Two Mpox Vaccines Amid Outbreak

Reuters (6/26, Rigby, Rolley) reports authorities in the Democratic Republic of Congo “have approved the use of two mpox vaccines to try to tackle an upsurge in cases and a dangerous new strain spreading in the country.” The country “has seen 20,000 cases and more than 1,000 deaths from mpox, mainly among children, since the start of last year.” Officials “issued an emergency use authorization for both Bavarian Nordic’s shot, Jynneos, and LC16, made by KM Biologics, according to documents and sources involved in the process.”